You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Bordetella pertussis antibody [BDI500] (ab24212)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Bordetella pertussis antibody [BDI500]

Description

Mouse monoclonal [BDI500] to Bordetella pertussis

Specificity

Specific for LOS-A of B. pertussis and B. bronchiseptica.

Tested applications

ELISA, IF, WBmore details

Cross reactivity

Reacts with Bordetella pertussis. Not yet tested in other species.

Immunogen

Bordetella pertussis N-lauroyl sarcosine membrane extract.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 0.01M PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein A purified

Purification notes

>90% pure.

Clonality

Monoclonal

Clone number

BDI500

Isotype

IgG3

Applications

Show applications key

Our Abpromise guarantee covers the use of ab24212 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ELISA

     
  • IF

     
  • WB

     

Application notes

ELISA: 1/20 - 1/200. IF: 1/10 - 1/50. WB: 1/10 - 1/50. Dilution optimised using Chromogenic detection.

Target

Relevance

Bordetella pertussis is an aerobic, gram negative coccobacilli. It causes whooping cough (pertussis), an acute respiratory infection marked by severe, spasmodic coughing episodes during the paroxysmal phase. Leukocytosis with lymphocytosis is also common during this phase of the illness. Dangerous complications are bronchopneumonia and acute encephalopathy. It produces a number of virulence factors, including pertussis toxin, adenylate cyclase toxin, filamentous hemagglutinin, and hemolysin. Agglutinogens and other outer membrane proteins are important antigens. Pertussis toxin (islet activating protein) is the major protein toxin produced by virulent strains of Bordetella pertussis. As revealed by polyacrylamide gel electrophoresis, the purified protein consists of five dissimilar subunits: S1 (MW 28,000), S2 (MW 23,000), S3 (MW 22,000), S4 (MW 11,700) and S5 (MW 9,300), in a molar ratio of 1:1:1:2:1. The A protomer, S1 is responsible for the enzymatic activity of the toxin. Together, S2, S3, S4 and S5 comprise the B oligomer, responsible for binding the toxin to the cell surface.

Alternative names

  • B.pertussis antibody

References for Anti-Bordetella pertussis antibody [BDI500] (ab24212)

ab24212 has not yet been referenced specifically in any publications.

Publishing research using ab24212? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"